TT223

· OPKO Health, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TT223, covering 2013-06-21 to 2013-06-21. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione [Phase 2]